CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis-Reference-Cited by-同舟云学术

CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis

Published:2022-07 Issue:4 Volume:21 Page:713-720
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Westhölter Dirk^ORCID,Schumacher Fabian^ORCID,Wülfinghoff Nuria,Sutharsan Sivagurunathan,Strassburg Svenja,Kleuser Burkhard,Horn Peter A,Reuter Sebastian,Gulbins Erich,Taube Christian,Welsner Matthias^ORCID

Funder

Universität Duisburg-Essen

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference34 articles.

1. Cystic fibrosis [Internet];Elborn;Lancet,2016

2. Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single phe508del allele [Internet];Middleton;N Engl J Med,2019

3. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation;Ramsey;N Engl J Med,2011

4. CFTR modulator therapy enhances peripheral blood monocyte contributions to immune responses in people with cystic fibrosis [Internet];Hisert;Front Pharmacol,2020

5. Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis [Internet];Jarosz-Griffiths;Elife,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study;Scientific Reports;2023-12-20

2. Fumonisins alone or mixed with other fusariotoxins increase the C22–24:C16 sphingolipid ratios in chickens and ducks, while deoxynivalenol and zearalenone have no effect;2023-12-19

3. Targeted sphingolipidomics indicates increased C22-C24:16 ratios of virtually all assayed classes in liver, kidney, and plasma of fumonisin-fed chickens;Ecotoxicology and Environmental Safety;2023-12

4. Decreased plasma levels of sphingolipids and total cholesterol in adult cystic fibrosis patients;Prostaglandins, Leukotrienes and Essential Fatty Acids;2023-10

5. Cross‐talk between CFTR and sphingolipids in cystic fibrosis;FEBS Open Bio;2023-06-22